Abstract

Aggregated alpha-synuclein (α-syn) is a principal constituent of Lewy bodies (LBs) and glial cytoplasmic inclusions (GCIs) observed respectively inside neurons in Parkinson’s disease (PD) and oligodendrocytes in multiple system atrophy (MSA). Yet, the cellular origin, the pathophysiological role, and the mechanism of formation of these inclusions bodies (IBs) remain to be elucidated. It has recently been proposed that α-syn IBs eventually cause the demise of the host cell by virtue of the cumulative sequestration of partner proteins and organelles. In particular, the hypothesis of a local cross-seeding of other fibrillization-prone proteins like tau or TDP-43 has also been put forward. We submitted sarkosyl-insoluble extracts of post-mortem brain tissue from PD, MSA and control subjects to a comparative proteomic analysis to address these points. Our studies indicate that: (i) α-syn is by far the most enriched protein in PD and MSA extracts compared to controls; (ii) PD and MSA extracts share a striking overlap of their sarkosyl-insoluble proteomes, consisting of a vast majority of mitochondrial and neuronal synaptic proteins, and (iii) other fibrillization-prone protein candidates possibly cross-seeded by α-syn are neither found in PD nor MSA extracts. Thus, our results (i) support the idea that pre-assembled building blocks originating in neurons serve to the formation of GCIs in MSA, (ii) show no sign of amyloid cross-seeding in either synucleinopathy, and (iii) point to the sequestration of mitochondria and of neuronal synaptic components in both LBs and GCIs.

Highlights

  • Synucleinopathies, such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB), or multiple system atrophy (MSA), are a group of neurodegenerative disorders of unknown etiology with very diverse clinical and pathological presentations

  • Intending to extract and identify the insoluble proteomes associated with aggregated α-syn for each synucleinopathy, we adapted the Sarkospin procedure to the purification of α-syn pathological assemblies found in human post-mortem tissue samples of PD and MSA subjects

  • The insoluble entities are collected in a dry pellet that is compatible with a further identification or quantification of its protein content by immunoblotting or mass spectrometry

Read more

Summary

Introduction

Synucleinopathies, such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB), or multiple system atrophy (MSA), are a group of neurodegenerative disorders of unknown etiology with very diverse clinical and pathological presentations. These diseases share certain standard features, the most significant being the aggregation of alpha-synuclein (α-syn), present in cytoplasmic inclusions bodies (IBs) in the cells of affected brain regions. These IBs are divergent in nature and cellular localization across these synucleinopathies. GCIs are packed triangle or sickle-shaped, filamentous structures5. α-syn is the principal filament constituent of both IBs2,5,6

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call